| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |